Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-01-16

FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)

Snippet

SUPPL AP for LIPITOR (ATORVASTATIN CALCIUM)